Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Furazolidone Containing Quadruple Therapy for First-line Helicobacter Pylori Eradication

NCT06823791 is registered in ClinicalTrials.gov with Liaocheng People's Hospital as lead sponsor.

NCT NCT06823791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06823791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Furazolidone Containing Quadruple Therapy for First-line Helicobacter Pylori Eradication
Lead sponsor
Liaocheng People's Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
August 1, 2022
Completion date
July 30, 2024
Enrollment
493 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eradication, helicobacter pylori infection